This means the risk was about 27% lower compared to metformin users
Clinical trials have shown that many patients experience gastrointestinal issues, including diarrhea, especially during the initial weeks of treatment
But if you are overweight or have mild obesity without associated diseases, the risks may or may not outweigh the benefits
[126] [127] As of January 20261.5 million users of compounded GLP-1 drugs (including semaglutide) in the United States, according to Novo Nordisk CEO Mike Doustdar
Increased flow is a reported side effect, particularly during the first few months of metabolic rebalancing
Additionally, my CRP (C-reactive protein) dropped to normal. Heidi, 60 years old, living with RA and sjogrens I am on Ozempic and my RA has actually gotten worse over the last 2 years